Michael Grissinger

Michael J.
Grissinger is currently Chairman at Kira Biotech Pty Ltd. since 2020.
Mr. Grissinger is Director at Atrin Pharmaceuticals LLC since 2018.
Mr. Grissinger is Independent Director at Aprea Therapeutics, Inc. since 2022.
Mr. Grissinger is Director at Atriva Therapeutics GmbH since 2020.
Mr. Grissinger is Director at Envisagenics, Inc. Mr. Grissinger is Independent Director at Adicet Bio, Inc. starting 2025.
Mr. Grissinger is Director at NephroDI Therapeutics, Inc. Mr. Grissinger is Director at AnaCardio AB. Mr. Grissinger is Independent Director at Lipocine, Inc. starting 2026.
Formerly, Mr. Grissinger was Independent Director at resTORbio, Inc. from 2018 to 2020.
Mr. Grissinger was Director at Atrin Pharmaceuticals, Inc. Mr. Grissinger was Independent Director at Akari Therapeutics Plc from 2018 to 2024.
Mr. Grissinger was Member-Management Board at Janssen Pharmaceuticals, Inc. Mr. Grissinger was VP & Head-Pharmaceutical Corporate Development at Johnson & Johnson.
Mr. Grissinger completed undergraduate studies at Juniata College.
Mr. Grissinger earned an MBA from Fox School of Business.